Mengozzi, A., Carli, F., Guiducci, L., Parolini, F., Biancalana, E., Gastaldelli, A., & Solini, A. (2021). SGLT2 inhibitors and thiazide enhance excretion of DEHP toxic metabolites in subjects with type 2 diabetes: A randomized clinical trial. Environmental research, 192, 110316. https://doi.org/10.1016/j.envres.2020.110316
Chicago Style (17th ed.) CitationMengozzi, Alessandro, Fabrizia Carli, Letizia Guiducci, Federico Parolini, Edoardo Biancalana, Amalia Gastaldelli, and Anna Solini. "SGLT2 Inhibitors and Thiazide Enhance Excretion of DEHP Toxic Metabolites in Subjects with Type 2 Diabetes: A Randomized Clinical Trial." Environmental Research 192 (2021): 110316. https://doi.org/10.1016/j.envres.2020.110316.
MLA (9th ed.) CitationMengozzi, Alessandro, et al. "SGLT2 Inhibitors and Thiazide Enhance Excretion of DEHP Toxic Metabolites in Subjects with Type 2 Diabetes: A Randomized Clinical Trial." Environmental Research, vol. 192, 2021, p. 110316, https://doi.org/10.1016/j.envres.2020.110316.